Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

680.65
+6.480.96%
Number of Gainers:85
Number of Losers:59
Number of Flat:9
PE:- -
High:687.10
Open:668.22
Low:668.22
Close:674.17
Volume:50.34M
Turnover:3.11B
Market Cap:468.87B
Float Cap:366.84B

Loading ...

Invivyd Plans FDA Accelerated-Approval BLA Filing for Vyd2311 COVID Antibody

Reuters
·
Sep 29

Deutsche Bank Trims Price Target on Robinhood Markets to $134 From $138, Keeps Buy Rating

MT Newswires Live
·
Sep 29

Unicycive Therapeutics announces resubmission of NDA for OLC

TIPRANKS
·
Sep 29

Aquestive Therapeutics appoints Daly to board of directors

TIPRANKS
·
Sep 29

Unicycive Resubmits FDA NDA for Oxylanthanum Carbonate Phosphate Binder

Reuters
·
Sep 29

Unicycive Therapeutics - FDA Acceptance of Nda Expected Within 30 Days; New Pdufa Date in 6 Months

THOMSON REUTERS
·
Sep 29

Unicycive Therapeutics - Nda Resubmission Includes Cmc Data from New Manufacturing Vendor

THOMSON REUTERS
·
Sep 29

Unicycive Therapeutics Announces Resubmission of New Drug Application for Oxylanthanum Carbonate

THOMSON REUTERS
·
Sep 29

Unicycive Therapeutics - FDA Inspection of Original Manufacturing Vendor Assigned but not Completed as of Sept 29, 2026

THOMSON REUTERS
·
Sep 29

Invivyd Says Liberty Phase 3 Trial Shows Vyd2311 Safety, Tolerability Top mRNA COVID-19 Vaccine

Reuters
·
Sep 29

Invivyd, - Vyd2311 Combined with Mrna Covid-19 Vaccine Adds to Neutralizing Titers Without Interference

THOMSON REUTERS
·
Sep 29

Invivyd, - Plans Bla Submission for Vyd2311 to FDA Via Accelerated Approval Program

THOMSON REUTERS
·
Sep 29

Invivyd Announces Positive Topline Results from Liberty Phase 3 Study Demonstrating Vyd2311 Safety and Tolerability Superior to Mrna-Based Covid-19 Vaccine; Announces Regulatory Submission Plans for Vyd2311

THOMSON REUTERS
·
Sep 29

Press Release: Aquestive Therapeutics Strengthens Board of Directors with Appointment of Richard Daly

Dow Jones
·
Sep 29

Alzamend Neuro Highlights Early AL001 Brain Lithium Data

TIPRANKS
·
Sep 29

Presidio Names J. Michael Bruff CFO Effective Oct. 5

Reuters
·
Sep 29

Summit Therapeutics secures major AstraZeneca equity partnership

TIPRANKS
·
Sep 29

Analysts Conflicted on These Technology Names: Duolingo (DUOL), Advanced Micro Devices (AMD) and Draganfly (DPRO)

TIPRANKS
·
Sep 29

Rapid Micro Biosystems Initiated at Buy by Roth Capital

Dow Jones
·
Sep 29

ThredUP expands into live shopping on Whatnot platform

TIPRANKS
·
Sep 29